Fig. 2.
Mixed-effects model results (estimates, 95% CIs) illustrating significant main effects of immune biomarkers on growth. (A) CRP vs. 1-wk growth. (B) IgG vs. 3-mo growth. (C) IgE vs. 20-mo growth. (D) IgE vs. height-for-age. Concentration of EBV-Ab was not significantly related to growth in any model.